Participating Faculty: The Clinical and Economic Consequences of Obesity

This supplement to The American Journal of Managed Care provides an overview of the considerable clinical, quality-of-life (QoL), and economic toll associated with obesity and obesity-related comorbidities. Also discussed are the cost-effectiveness of interventions to treat obesity and the impact of weight loss on health outcomes, costs, and QoL.This supplement was supported by VIVUS, INC.

Faculty

Caroline M. Apovian, MD

Director

Nutrition and Weight Management Center

Boston Medical Center

Boston, Massachusetts

Professor of Medicine

Boston University School of Medicine

Boston, Massachusetts

Faculty Disclosures

Caroline M. Apovian, MD, reports relationships with the following organizations:

Advisory boards: Amylin Pharmaceuticals, Arena Pharmaceuticals, Johnson & Johnson, Merck, Nutrisystem, sanofi-aventis, and Zafgen

Grants: Amylin Pharmaceuticals, Dr. Robert C. and Veronica Atkins Foundation, Eli Lilly and Company, MetaProteomics, Orexigen Therapeutics, Pfizer, and sanofi-aventis

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Download PDF: Participating Faculty: The Clinical and Economic Consequences of Obesity